Legal Compliance

The FDA Just Flagged a Jeuveau Instagram Reel. Aesthetics and Wellness Centers Post Similar Claims Every Day.

Dr. Kate Dee

Published on: 06/10/2026

The FDA told Evolus its Jeuveau Instagram reel was misleading. What FDA and FTC advertising rules require, and why medspa posts make the same claims.

Jeuveau FDA untitled letterEvolus Instagram misleadingfalse advertising in medicinemedspa advertising rulesBotox advertising complianceFTC health claims substantiationcompetent and reliable scientific evidenceprescription drug promotionboxed warning botulinum toxinmedspa social media compliancewellness clinic advertisingpatient testimonials advertisingmedspa marketing legal complianceneurotoxin marketing claimsMedSpa Board certification

“Research Use Only” Is Not a Loophole. Where Peptides Stand Right Now.

Dr. Kate Dee

Published on: 05/10/2026

The FDA warned five research-use-only peptide sellers, and state boards now bar licensees from giving these peptides to patients. Here is where the law stands.

research use only peptidesRUO peptidesare peptides legalFDA peptide warning letterspeptide crackdown 2026state medical board peptidesresearch-grade peptidesBPC-157 legal statusretatrutide legalcompounded peptides503A bulk drug substancesmedspa compliancemedspa peptide therapypeptide injection risksMedSpa Board certification

Empower Pharmacy is in trouble with the FDA. Is Your GLP-1 Supplier Next?

Dr. Kate Dee

Published on: 02/10/2026

The FDA sent Empower Pharmacy a third warning letter in 18 months over compounded GLP-1s. What it means for medspas prescribing semaglutide and tirzepatide.

compounded GLP-1compounded semaglutidecompounded tirzepatideEmpower PharmacyFDA warning lettercompounding pharmacymedspa compliancemedspa weight loss

Two Saline Recalls in Two Weeks. Have You Checked Your IV Bags?

Dr. Kate Dee

Published on: 29/09/2026

Baxter and B. Braun recalled 0.9% saline lots for fiberglass and iron oxide particles. Here are the lot numbers and what IV practices must do now.